Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Population Groups

Differences in cancer outcomes persist between population groups in a wide range of measures. These measures include incidence, prevalence, morbidity, mortality, survivorship, quality of life after cancer treatment, screening rates, stage at diagnosis, and burden of cancer or related health conditions. Complex and interrelated factors contribute to the observed differences in cancer outcomes, including access to healthcare, socioeconomic factors, differences in diet and lifestyle, ancestry-related risk factors, persistent co-morbidities, and chronic stress exposure. An increasing number of studies demonstrate that even when socioeconomic and access to care factors are accounted for, incidence and mortality gaps persist between populations for some cancer types. Moreover, advances in genomics and other molecular technologies are improving our understanding of how biological differences among population groups contribute to differences in cancer outcomes and how biological factors interact with other potentially relevant factors, such as diet.

University of Hawai‘i
Lung & Breast

Fred Hutchinson Cancer Center
GI

University of Texas MD Anderson Cancer Center
Lymphoma

University of North Carolina Chapel Hill
Endometrial

University of California San Francisco
Meningioma, Prostate & Breast 

University of Miami Sylvester, Emory Winship and Morehouse School of Medicine
Anal & Cervical

Baylor College of Medicine, Emory University and University of California San Francisco
Acute Lymphoblastic Leukemia

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Population Groups was originally published by the National Cancer Institute.”

Email